| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 449 |
| 1 | PREDNISONE | 442 |
| 2 | FUROSEMIDE | 426 |
| 3 | ASPIRIN | 423 |
| 4 | METHOTREXATE SODIUM | 413 |
| 5 | ASPIRIN 325 MG | 409 |
| 6 | ASPIRIN 81 MG | 409 |
| 7 | METHOTREXATE | 384 |
| 8 | CYCLOPHOSPHAMIDE | 382 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 382 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BERACTANT | 126 | 0.3415 |
| 1 | PORACTANT ALFA | 78 | 0.1058 |
| 2 | IBUPROFEN LYSINE | 20 | 0.0351 |
| 3 | CANGRELOR | 8 | 0.0198 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 164 | 0.0196 |
| 5 | NELARABINE | 18 | 0.0185 |
| 6 | NITRIC OXIDE | 84 | 0.0182 |
| 7 | EPTIFIBATIDE | 14 | 0.0181 |
| 8 | BIVALIRUDIN | 14 | 0.0141 |
| 9 | DEFIBROTIDE SODIUM | 48 | 0.0134 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1212 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 819 |
| 2 | Factor Xa Inhibitor [EPC] | 674 |
| 3 | Alkylating Drug [EPC] | 507 |
| 4 | Loop Diuretic [EPC] | 462 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 456 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 443 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 421 |
| 8 | Kinase Inhibitor [EPC] | 394 |
| 9 | Platinum-based Drug [EPC] | 360 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 207 | 0.1780 |
| 1 | Antivenin [EPC] | 1 | 0.0526 |
| 2 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 3 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 4 | CD33-directed Immunoconjugate [EPC] | 37 | 0.0101 |
| 5 | Prostacycline [EPC] | 6 | 0.0064 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 82 | 0.0064 |
| 7 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 5 | 0.0061 |
| 8 | Asparagine-specific Enzyme [EPC] | 78 | 0.0058 |
| 9 | Anti-coagulant [EPC] | 21 | 0.0056 |